Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1202 participants
OBSERVATIONAL
2024-01-01
2024-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predict 5-Year Survival in Elderly Gastric Cancer
NCT06208046
Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients
NCT06548464
Prediction Model for Advanced Gastric Cancer in Elderly
NCT06467591
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907
Multi-center and Multi-modal Deep Learning Study of Gastric Cancer
NCT05001321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The analysis employs the Random Survival Forest (RSF) method, incorporating variable importance and minimal depth techniques to select key variables for predicting overall survival (OS) and disease-free survival (DFS). The study also implements rigorous data handling procedures, including multiple imputations for missing data.
The development of an online prognostic tool based on the RSF model is part of the project, designed to provide real-time survival predictions through a user-friendly interface for clinical application.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed diagnosis of gastric cancer.
* Patients who have undergone curative gastrectomy.
Exclusion Criteria
* Pathological confirmation of metastatic disease (M1).
* Incomplete follow-up data or loss to follow-up.
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang-Ming Huang, Prof.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chang-Ming Huang, Prof.
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chang-Ming Huang, M.D
Role: PRINCIPAL_INVESTIGATOR
Fujian Medical University Union Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastric Surgery, Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024KY074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.